Collegium Pharmaceutical (COLL) and Paris Hilton are collaborating to share her personal experience living with attention-deficit/hyperactivity disorder, ADHD, and her treatment journey. Through this collaboration, Paris aims to reduce stigma and encourage others living with ADHD to speak with their healthcare provider about finding a treatment plan that works best for them.
Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on COLL: